Tag: Foam
-
Arcutis Will get FDA Nod for Topical Foam
Westlake Village-based immunodermatology firm Arcutis Biotherapeutics Inc. has acquired approval from the Meals and Drug Administration for a topical foam model of its primary drug to deal with seborrheic dermatitis in people aged 9 and older. The approval, introduced final month, marks the primary new methodology of utility for a drug to deal with seborrheic…